Integrated DNA Technologies (IDT), a specialist in oligonucleotide synthesis, is set to exhibit at the qPCR 2011 show in Munich, Germany, from 28 March to 1 April.
Key personnel will be found in Booth 16 to provide advice and support to delegates.
Dr Scott Rose, director of molecular genetics at IDT, will deliver a talk, entitled 'Primetime Pre-designed qPCR Assays using Zen Internal Dark Quencher Chemistry'.
Well-designed qPCR assays require the careful consideration of primer placement, specificity, the avoidance of SNPs, oligo interactions and accurate Tm calculations, according to the company.
In order to meet these requirements, IDT now offers Primetime pre-designed qPCR assays for all genes in the human, mouse and rat genome.
These assays avoid any cross reactivity within that genome, known SNPs and primer interactions, while providing a full disclosure of all sequence information, as recommended by MIQE guidelines.
By including the Zen double-quenched probes, these assays provide outstanding levels of sensitivity, with the added security of knowing precise probe location.
IDT's Zen double-quenched probe technology increases the accuracy and reliability of 5' nuclease qPCR experiments by positioning an internal Zen quencher nine bases from the 5' fluorophore.
When combined with the standard 3' quencher, this decreases background fluorescence and increases sensitivity.
The initial background fluorescence signal is therefore much lower, making subsequent changes easily detectable.
As a result, low background is obtained, even at 40 base pairs or longer.
